دورية أكاديمية

Doxifluridine-conjugated 2-5A analog shows strong RNase L activation ability and tumor suppressive effect.

التفاصيل البيبلوغرافية
العنوان: Doxifluridine-conjugated 2-5A analog shows strong RNase L activation ability and tumor suppressive effect.
المؤلفون: Kitamura, Yoshiaki1,2, Kito, Seiya1, Nakashima, Remi1, Tanaka, Katsuki1, Nagaoka, Kumi3, Kitade, Yukio1,2,3,4 ykkitade@gifu-u.ac.jp
المصدر: Bioorganic & Medicinal Chemistry. Aug2016, Vol. 24 Issue 16, p3870-3874. 5p.
مصطلحات موضوعية: *RIBONUCLEASE L, *OLIGOADENYLATES, *TUMOR suppressor genes, *CERVICAL cancer, *BINDING sites
مستخلص: RNase L is activated by 2′,5′-oligoadenylates (2-5A) at subnanomolar levels to cleave single-stranded RNA. We previously reported the hypothesis that the introduction of an 8-methyladenosine residue at the 2′-terminus of the 2-5A tetramer shifts the 2-5A binding site of RNase L. In this study, we synthesized various 5′-modified 2-5A analogs with 8-methyladenosine at the 2′-terminus. The doxifluridine-conjugated 8-methyladenosine-substituted 2-5A analog was significantly more effective as an activator of RNase L than the parent 5′-monophophorylated 2-5A tetramer and showed a tumor suppressive effect against human cervical cancer cells. [ABSTRACT FROM AUTHOR]
قاعدة البيانات: Academic Search Index
ResultId 1
Header asx
Academic Search Index
116864391
1243
6
Academic Journal
academicJournal
1242.88415527344
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=116864391&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Doxifluridine-conjugated 2-5A analog shows strong RNase L activation ability and tumor suppressive effect. )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Kitamura%2C+Yoshiaki%22">Kitamura, Yoshiaki</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Kito%2C+Seiya%22">Kito, Seiya</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Nakashima%2C+Remi%22">Nakashima, Remi</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Tanaka%2C+Katsuki%22">Tanaka, Katsuki</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Nagaoka%2C+Kumi%22">Nagaoka, Kumi</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Kitade%2C+Yukio%22">Kitade, Yukio</searchLink><relatesTo>1,2,3,4</relatesTo><i> ykkitade@gifu-u.ac.jp</i> )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <searchLink fieldCode="JN" term="%22Bioorganic+%26+Medicinal+Chemistry%22">Bioorganic & Medicinal Chemistry</searchLink>. Aug2016, Vol. 24 Issue 16, p3870-3874. 5p. )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => *<searchLink fieldCode="DE" term="%22RIBONUCLEASE+L%22">RIBONUCLEASE L</searchLink><br />*<searchLink fieldCode="DE" term="%22OLIGOADENYLATES%22">OLIGOADENYLATES</searchLink><br />*<searchLink fieldCode="DE" term="%22TUMOR+suppressor+genes%22">TUMOR suppressor genes</searchLink><br />*<searchLink fieldCode="DE" term="%22CERVICAL+cancer%22">CERVICAL cancer</searchLink><br />*<searchLink fieldCode="DE" term="%22BINDING+sites%22">BINDING sites</searchLink> )
Array ( [Name] => Abstract [Label] => Abstract [Group] => Ab [Data] => RNase L is activated by 2′,5′-oligoadenylates (2-5A) at subnanomolar levels to cleave single-stranded RNA. We previously reported the hypothesis that the introduction of an 8-methyladenosine residue at the 2′-terminus of the 2-5A tetramer shifts the 2-5A binding site of RNase L. In this study, we synthesized various 5′-modified 2-5A analogs with 8-methyladenosine at the 2′-terminus. The doxifluridine-conjugated 8-methyladenosine-substituted 2-5A analog was significantly more effective as an activator of RNase L than the parent 5′-monophophorylated 2-5A tetramer and showed a tumor suppressive effect against human cervical cancer cells. [ABSTRACT FROM AUTHOR] )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1016/j.bmc.2016.06.033 ) ) [Languages] => Array ( [0] => Array ( [Code] => eng [Text] => English ) ) [PhysicalDescription] => Array ( [Pagination] => Array ( [PageCount] => 5 [StartPage] => 3870 ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => RIBONUCLEASE L [Type] => general ) [1] => Array ( [SubjectFull] => OLIGOADENYLATES [Type] => general ) [2] => Array ( [SubjectFull] => TUMOR suppressor genes [Type] => general ) [3] => Array ( [SubjectFull] => CERVICAL cancer [Type] => general ) [4] => Array ( [SubjectFull] => BINDING sites [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Doxifluridine-conjugated 2-5A analog shows strong RNase L activation ability and tumor suppressive effect. [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Kitamura, Yoshiaki ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Kito, Seiya ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Nakashima, Remi ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Tanaka, Katsuki ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Nagaoka, Kumi ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Kitade, Yukio ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 15 [M] => 08 [Text] => Aug2016 [Type] => published [Y] => 2016 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 09680896 ) ) [Numbering] => Array ( [0] => Array ( [Type] => volume [Value] => 24 ) [1] => Array ( [Type] => issue [Value] => 16 ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Bioorganic & Medicinal Chemistry [Type] => main ) ) ) ) ) ) )
IllustrationInfo